The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $706,647
- $4,329,223 in all
- Institutions
- 7
- 7 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
7
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- GEORGETOWN UNIVERSITY1
- H. LEE MOFFITT CANCER CTR & RES INST1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZDE1 AC (02))6
- ZDE1-AC(01)1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition1U01CA290479-01 | Alexandrov, Ludmil BGutkind, Jorge SilvioLippman, Scott M | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $790,000 | Study section ZDE1 |
| FY2023 | Immune and transcriptomic biomarkers of progressive oral premalignant lesions1U01DE033351-01 | Momen Heravi, Fatemeh | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $743,064 | Study section ZDE1 |
| FY2023 | Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)1U01DE033329-01 | Amelio, Antonio LuigiGiuliano, Anna R. | H. LEE MOFFITT CANCER CTR & RES INST, FL | First-year cost $727,078 | Study section ZDE1 |
| FY2023 | Oral Dysplasias to Carcinomas: Multi-omics Study of Progression1U01DE033348-01 | Rozek, Laura | GEORGETOWN UNIVERSITY, DC | First-year cost $706,647 | Study section ZDE1 |
| FY2023 | Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy1U01DE033330-01 | Chinn, Steven BennettLei, Yu LeoWang, Thomas D | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $689,330 | Study section ZDE1 |
| FY2023 | Combined Imaging and RNA Analyses to Predict Head and Neck Cancer Recurrence1R56DE033344-01 | Li, HuaWang, Xiaowei | WASHINGTON UNIVERSITY, MO | First-year cost $673,102 | Study section ZDE1 |
| FY2023 | Early detection and risk of head and neck cancer through immune based spatial omics1U01DE033324-01 | Pai, Sara IsabelWeissleder, Md, Phd, Ralph | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $2 | Study section ZDE1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.